San Diego-primarily based Viking Therapeutics marked alone as a significant competitor inside the weight loss drug marketplace in February immediately after revealing promising info from a mid-stage trial of experimental drug VK2735, which recommended it rivaled—and outperformed—Novo and Lilly drugs when offered like a weekly injection As well